Managing patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia

被引:19
作者
McNaughton-Collins, M [1 ]
Barry, MJ [1 ]
机构
[1] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA
关键词
benign prostatic hyperplasia; diagnosis; treatment;
D O I
10.1016/j.amjmed.2004.12.033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Many men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia can be managed safely and effectively by primary care providers. After a basic evaluation to exclude other diseases that may cause lower urinary tract symptoms, quantifying the degree of symptoms and bother,and perhaps making an assessment of prostate size, the primary care provider can determine which men require immediate evaluation by a urologist and which men may choose among various treatment options, including watchful waiting and various single agent or combination medication strategies. Recent information about risk factors for disease progression has also helped to inform patient decisions on which treatment option is best for the individual patient. The purpose of this review is to provide primary care providers with an approach to the management of men with lower Urinary tract symptoms suggestive of benign prostatic hyperplasia. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1331 / 1339
页数:9
相关论文
共 59 条
[1]   NEW WORDS FOR OLD - LOWER URINARY-TRACT SYMPTOMS FOR PROSTATISM [J].
ABRAMS, P .
BRITISH MEDICAL JOURNAL, 1994, 308 (6934) :929-930
[2]   IN SUPPORT OF PRESSURE-FLOW STUDIES FOR EVALUATING MEN WITH LOWER URINARY-TRACT SYMPTOMS [J].
ABRAMS, P .
UROLOGY, 1994, 44 (02) :153-155
[3]  
Abrams P, 1996, SCAND J UROL NEPHROL, V30, P47
[4]  
American Urological Association, 2003, J UROLOGY, V170, P530
[5]   Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia [J].
Andersen, JT ;
Nickel, JC ;
Marshall, VR ;
Schulman, CC ;
Boyle, P .
UROLOGY, 1997, 49 (06) :839-845
[6]   Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: Results of a randomized, double-blind, placebo-controlled clinical trial [J].
Andriole, GL ;
Guess, HA ;
Epstein, JI ;
Wise, H ;
Kadmon, D ;
Crawford, ED ;
Hudson, P ;
Jackson, CL ;
Romas, NA ;
Patterson, L ;
Cook, TJ ;
Waldstreicher, J .
UROLOGY, 1998, 52 (02) :195-201
[7]  
[Anonymous], 1994, BENIGN PROSTATIC HYP
[8]  
BARRY MJ, 1995, MED CARE, V33, pAS145
[9]   THE AMERICAN-UROLOGICAL-ASSOCIATION SYMPTOM INDEX FOR BENIGN PROSTATIC HYPERPLASIA [J].
BARRY, MJ ;
FOWLER, FJ ;
OLEARY, MP ;
BRUSKEWITZ, RC ;
HOLTGREWE, HL ;
MEBUST, WK ;
COCKETT, ATK ;
BLAIVAS, JG ;
WEIN, AJ .
JOURNAL OF UROLOGY, 1992, 148 (05) :1549-1557
[10]   The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists [J].
Barry, MJ ;
Fowler, FJ ;
Bin, L ;
Pitts, JC ;
Harris, CJ ;
Mulley, AG .
JOURNAL OF UROLOGY, 1997, 157 (01) :10-14